Cordis Pipeline Includes Stents, A-Fib Ablation, Percutaneous AAA Repair
This article was originally published in The Gray Sheet
Executive Summary
Cordis will file a PMA in 2011 for its Nevo drug-eluting, cobalt chromium coronary stent with reservoir-based delivery technology gained through the 2007 acquisition of Conor Medsystems, the Johnson & Johnson subsidiary says